Target intelligence / Profile preview

Chromodomain-helicase-DNA-binding protein 7 (AeCHD7) (AeCHD7)

Target
AeCHD7
Molecular classification
Enzyme, Transcription factor, Chromatin remodeler, SNF2-family helicase
01

Overview

AeCHD7 is a chromatin-remodeling protein in the Aedes aegypti mosquito, belonging to the Chromodomain-helicase-DNA-binding (CHD) family and serving as the ortholog of the Drosophila Kismet protein. It contains conserved chromodomains, an SNF2-related helicase domain, and BRK domains, which allow it to regulate gene expression by modifying chromatin structure. Research has identified AeCHD7 as a critical pro-viral host factor for the Dengue virus (DENV); its expression is significantly upregulated during infection, and its presence is necessary for efficient viral replication. Experimental depletion of AeCHD7 via RNA interference has been shown to severely reduce DENV titers in mosquito tissues. Furthermore, AeCHD7 is a key target in Wolbachia-mediated pathogen blocking, as Wolbachia infection leads to the downregulation of AeCHD7, thereby contributing to the mosquito's resistance to viral pathogens. Given its central role in determining vector competence, AeCHD7 is considered a promising target for genetic or chemical interventions aimed at controlling the transmission of arboviruses like Dengue and Zika. However, therapeutic development must account for the high conservation of CHD7 in humans to avoid serious off-target effects, as human CHD7 mutations are linked to the developmental disorder CHARGE syndrome.

Other names
KismetAAEL002230CHD7Chromodomain-helicase-DNA-binding protein 7
02

Mechanism of action

Inhibition of viral replication through the depletion or downregulation of essential pro-viral host factors required for the viral life cycle.

03

Biological functions

Chromatin remodelingViral replicationRegulation of transcriptionHost-virus interaction
04

Disease associations

DengueZikaInfection
05

Safety considerations

Potential off-target effects on human CHD7 orthologAssociation of human CHD7 mutations with CHARGE syndromeSpecies-specific delivery and targeting challenges
06

Biomarkers

AeCHD7 mRNA expression levelsAeCHD7 protein levels in salivary glands

Beyond the preview

Go deeper on Chromodomain-helicase-DNA-binding protein 7 (AeCHD7) (AeCHD7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromodomain-helicase-DNA-binding protein 7 (AeCHD7) (AeCHD7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call